412 related articles for article (PubMed ID: 21472131)
1. Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma.
Kosriwong K; Menheniott TR; Giraud AS; Jearanaikoon P; Sripa B; Limpaiboon T
World J Gastroenterol; 2011 Mar; 17(12):1631-41. PubMed ID: 21472131
[TBL] [Abstract][Full Text] [Related]
2. A novel TFF2 splice variant (∆EX2TFF2) correlates with longer overall survival time in cholangiocarcinoma.
Kamlua S; Patrakitkomjorn S; Jearanaikoon P; Menheniott TR; Giraud AS; Limpaiboon T
Oncol Rep; 2012 Apr; 27(4):1207-12. PubMed ID: 22159958
[TBL] [Abstract][Full Text] [Related]
3. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors.
Andersen JB; Spee B; Blechacz BR; Avital I; Komuta M; Barbour A; Conner EA; Gillen MC; Roskams T; Roberts LR; Factor VM; Thorgeirsson SS
Gastroenterology; 2012 Apr; 142(4):1021-1031.e15. PubMed ID: 22178589
[TBL] [Abstract][Full Text] [Related]
4. Amplification of chromosome 21q22.3 harboring trefoil factor family genes in liver fluke related cholangiocarcinoma is associated with poor prognosis.
Muenphon K; Limpaiboon T; Jearanaikoon P; Pairojkul C; Sripa B; Bhudhisawasdi V
World J Gastroenterol; 2006 Jul; 12(26):4143-8. PubMed ID: 16830362
[TBL] [Abstract][Full Text] [Related]
5. [Trefoil factor family gene and peptide expression in pterygium].
Lafontaine PO; Arnal M; Buron N; Solary E; Lizard S; Bron A; Bara J; Gespach C; Creuzot-Garcher C
J Fr Ophtalmol; 2003 Dec; 26(10):1007-14. PubMed ID: 14691392
[TBL] [Abstract][Full Text] [Related]
6. Enhanced expression of mucin 6 glycoprotein in cholangiocarcinoma tissue from patients in Thailand as a prognostic marker for survival.
Thuwajit P; Chawengrattanachot W; Thuwajit C; Sripa B; Paupairoj A; Chau-In S
J Gastroenterol Hepatol; 2008 May; 23(5):771-8. PubMed ID: 18410610
[TBL] [Abstract][Full Text] [Related]
7. Trefoil factor family mRNA and protein expression in pterygium.
Lafontaine PO; Arnal M; Buron N; Solary E; Bron AM; Westley BR; May FE; Bara J; Gespach C; Creuzot-Garcher C
Int J Oncol; 2005 Oct; 27(4):997-1003. PubMed ID: 16142316
[TBL] [Abstract][Full Text] [Related]
8. Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer.
Qu Y; Yang Y; Ma D; Xiao W
Oncol Rep; 2012 Apr; 27(4):1277-83. PubMed ID: 22246423
[TBL] [Abstract][Full Text] [Related]
9. EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma.
Hoffmann AC; Goekkurt E; Danenberg PV; Lehmann S; Ehninger G; Aust DE; Stoehlmacher-Williams J
PLoS One; 2013; 8(5):e64186. PubMed ID: 23704979
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and localization of trefoil factor family (TFF) peptides in the human urinary tract and TFF2 excretion into the urine.
Rinnert M; Hinz M; Buhtz P; Reiher F; Lessel W; Hoffmann W
Cell Tissue Res; 2010 Mar; 339(3):639-47. PubMed ID: 20063012
[TBL] [Abstract][Full Text] [Related]
11. TFF peptides in the human efferent tear ducts.
Paulsen FP; Hinz M; Schaudig U; Thale AB; Hoffmann W
Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3359-64. PubMed ID: 12407144
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of trefoil factor family 1 in biliary epithelium in hepatolithiasis and cholangiocarcinoma.
Sasaki M; Tsuneyama K; Nakanuma Y
Lab Invest; 2003 Oct; 83(10):1403-13. PubMed ID: 14563942
[TBL] [Abstract][Full Text] [Related]
13. Oncogenic potential of cyclin kinase subunit-2 in cholangiocarcinoma.
Shen DY; Zhan YH; Wang QM; Rui G; Zhang ZM
Liver Int; 2013 Jan; 33(1):137-48. PubMed ID: 23121546
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of cholangiocarcinoma-derived fibroblast reveals alterations related to tumor progression and indicates periostin as a poor prognostic marker.
Utispan K; Thuwajit P; Abiko Y; Charngkaew K; Paupairoj A; Chau-in S; Thuwajit C
Mol Cancer; 2010 Jan; 9():13. PubMed ID: 20096135
[TBL] [Abstract][Full Text] [Related]
15. Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line.
Yoon JH; Higuchi H; Werneburg NW; Kaufmann SH; Gores GJ
Gastroenterology; 2002 Apr; 122(4):985-93. PubMed ID: 11910351
[TBL] [Abstract][Full Text] [Related]
16. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
[TBL] [Abstract][Full Text] [Related]
17. TFF peptides and mucins are major components of dacryoliths.
Paulsen FP; Schaudig U; Fabian A; Ehrich D; Sel S
Graefes Arch Clin Exp Ophthalmol; 2006 Sep; 244(9):1160-70. PubMed ID: 16453128
[TBL] [Abstract][Full Text] [Related]
18. Chronic rhinosinusitis without nasal polyps is associated with increased expression of trefoil factor family peptides.
Li P; Turner JH
Int Forum Allergy Rhinol; 2014 Jul; 4(7):571-6. PubMed ID: 24733740
[TBL] [Abstract][Full Text] [Related]
19. Alterations in chemokine receptor CCR5 activity influence tumor cell biology in human cholangiocarcinoma cell lines.
Yang J; Sontag D; Gong Y; Minuk GY
Ann Hepatol; 2021; 21():100265. PubMed ID: 33045415
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
